These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

740 related items for PubMed ID: 15906363

  • 1. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
    Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Sasahara H, Shirouzu K, Suzuki G, Hayabuchi N, Inutsuka H.
    J Surg Oncol; 2005 Jun 15; 90(4):209-19. PubMed ID: 15906363
    [Abstract] [Full Text] [Related]

  • 2. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 3. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H, Nemoto K, Miyazaki S, Yoshioka T, Ogawa Y, Sakayauchi T, Jingu K, Miyata G, Onodera K, Ichikawa H, Kamei T, Kato S, Ishioka C, Satomi S, Yamada S.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):348-56. PubMed ID: 19735862
    [Abstract] [Full Text] [Related]

  • 4. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 5. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.
    Fujiwara Y, Kamikonya N, Inoue T, Koishi K, Yoshikawa R, Nakao K, Yagyu R, Nishiwaki M, Fujiwara M, Kojima S, Nakagawa K, Yamamura T.
    Oncol Rep; 2005 Nov 01; 14(5):1177-82. PubMed ID: 16211282
    [Abstract] [Full Text] [Related]

  • 6. Chemoradiotherapy with and without esophagectomy for advanced esophageal cancer.
    Nakamura T, Ota M, Hayashi K, Eguchi R, Ide H, Takasaki K, Mitsuhashi N.
    Hepatogastroenterology; 2006 Nov 01; 53(71):705-9. PubMed ID: 17086873
    [Abstract] [Full Text] [Related]

  • 7. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N, Yano M, Takachi K, Kishi K, Noura S, Eguchi H, Yamada T, Miyashiro I, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Doki Y, Imaoka S.
    J Surg Oncol; 2009 Apr 01; 99(5):302-6. PubMed ID: 19170110
    [Abstract] [Full Text] [Related]

  • 8. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
    Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Nishida T, Mori M, Doki Y.
    J Surg Oncol; 2009 Nov 01; 100(6):442-6. PubMed ID: 19653262
    [Abstract] [Full Text] [Related]

  • 9. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK, Chiu PW, Leung SF, Cheung KY, Chan AC, Au-Yeung AC, Griffith JF, Chung SS, Ng EK.
    Ann Surg Oncol; 2008 Feb 01; 15(2):576-82. PubMed ID: 18057993
    [Abstract] [Full Text] [Related]

  • 10. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
    Yamada K, Murakami M, Okamoto Y, Okuno Y, Nakajima T, Kusumi F, Takakuwa H, Matsusue S.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1106-11. PubMed ID: 16504758
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M.
    Jpn J Clin Oncol; 2004 Oct 15; 34(10):615-9. PubMed ID: 15591460
    [Abstract] [Full Text] [Related]

  • 12. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW, Blanke CD, Wu H, Shyr Y, Berlin J, Beauchamp RD, Chakravarthy B.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):397-404. PubMed ID: 17097833
    [Abstract] [Full Text] [Related]

  • 13. Preoperative chemoradiotherapy for esophageal cancer enhances the postoperative systemic inflammatory response.
    Tsujimoto H, Ono S, Chochi K, Sugasawa H, Ichikura T, Mochizuki H.
    Jpn J Clin Oncol; 2006 Oct 01; 36(10):632-7. PubMed ID: 17020895
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun 01; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

  • 15. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S, Sugiyama T, Ueno Y, Okamoto H, Takasawa S, Nanjo H, Watanabe H, Maruyama K, Okuyama M, Ogawa J.
    Ann Surg Oncol; 2006 Dec 01; 13(12):1724-31. PubMed ID: 17009160
    [Abstract] [Full Text] [Related]

  • 16. [Neoadjuvant chemoradiotherapy for advanced squamous cell carcinoma of thoracic esophagus].
    Takahashi S, Sato Y, Kondo M, Kudo T, Shimokuni T, Maeda Y, Honnma S, Shinohara T, Kohashi S, Todo S.
    Gan To Kagaku Ryoho; 2004 Jan 01; 31(1):45-9. PubMed ID: 14750320
    [Abstract] [Full Text] [Related]

  • 17. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
    Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A.
    Cancer; 2001 Jun 01; 91(11):2165-74. PubMed ID: 11391598
    [Abstract] [Full Text] [Related]

  • 18. [A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma].
    An FS, Huang JQ, Xie YT, Chen SH, Rong TH.
    Zhonghua Zhong Liu Za Zhi; 2003 Jul 01; 25(4):376-9. PubMed ID: 12921571
    [Abstract] [Full Text] [Related]

  • 19. [Chemoradiotherapy for esophageal cancer].
    Fujita H, Sueyoshi S, Tanaka T, Sasahara H, Matono S, Yamana H, Shirouzu K, Suzuki G, Hayabuchi N.
    Gan To Kagaku Ryoho; 2003 Jul 01; 30(7):937-43. PubMed ID: 12894707
    [Abstract] [Full Text] [Related]

  • 20. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.
    Kato H, Fukuchi M, Manda R, Faried A, Takita J, Nakajima M, Miyazaki T, Sohda M, Fukai Y, Masuda N, Tsukada K, Kuwano H.
    Anticancer Res; 2004 Jul 01; 24(6):4091-6. PubMed ID: 15736457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.